BioDelivery Sciences: Undervalued With Buyout Potential
November 10, 2015 at 19:00 PM EST
BioDelivery Sciences International has a market capitalization of just over $300 million, enough cash on hand to fund itself through at least mid-2017 and has one approved product on the market and one more on the way.